The incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 1, 2011, Pages 17-20

  Singh, Harminder ^a   Kumar, Bithika Nel ^a   Sinha, Tiku ^b   Dulhani, Navin ^a  

^a Government Medical College   (India)

^b PSM   (India)

Author keywords

Adverse drug reactions; drug related problems; over the counter drug

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRESCRIPTION; TERTIARY HEALTH CARE;

EID: 84855786532     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.77095     Document Type: Article

References (19)

1. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharmaceut J 2003;270:583-6.
2. Patel P, Zed PJ. Drug-related visits to the emergency department: How big is the problem? Pharmacotherapy 2002;22:915-23.
3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
4. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.
5. Lee A, Thomas SH. Pharmacovigilance. In: Walker R, Edwards C, editors. Clinical Pharmacy and Therapeutics. 3rd Ed. London: Churchill Livingstone; 2003. p. 33-46.
6. Winterstein AG, Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R, Kanjanarat P. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health Syst Pharm 2004;61:1908-16.
7. Zed PJ. Drug-related visits to the emergency department. J Pharm Pract 2005;18:329-35.
8. World Health Organization. International drug monitoring: The role of the hospital. Geneva: World Health Organization; 1996. (Technical report series: No 425.)
9. van Mil JW, Westerlund LT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67.
10. Forster AJ, Shojania KG, van Walraven C. Improving patient safety: moving beyond the "hype" of medical errors. CMAJ 2005;173:893-4.
11. Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy 2004;24:1491-8.
12. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as a cause of admission to hospital: Prospective analysis of 18820 patients. BMJ 2004;329:15-9.
13. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170:345-9.
14. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug Reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-6.
15. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Adverse drug reactions in a department of systemic disease-oriented internal medicine: Prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000;56:181-6.
16. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36:1092-8.
17. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007;34:494-8.
18. English, Tom. Drug-related problems: Once a $76.6 billion headache, now a $177.4 billion migraine. Pharma Today 2001;7:1-10.
19. Shojania KG. Safe medication prescribing and monitoring in the outpatient setting. CMAJ 2006;174:1257-9.